News – Page 431 – Endpoints News

Bayer drops an Ionis-partnered drug after sinking $240M into its development

3 years ago

Amgen on IRA's drug price negotiations: 'Material adverse effect' on sales, business and operations

3 years ago

After a one-year gap, Sage finally finds new CMO; Gutted by layoffs, Flagship's Rubius reshuffles a not-so-full deck

3 years ago

Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators

3 years ago

Exclusive: Mt. Everest almost got in the way of a tRNA biotech, but hC Bioscience climbs to Series A extension

3 years ago

Scoop: Calling off an IPO, a cancer and Covid-19 vaccine maker raises a Series C

3 years ago

'Forward, faster' and 200 jobs lighter as fibrosis and kidney disease get cut, Galapagos CEO Stoffels once again ...

3 years ago

Merck confronts stigma and fear around lung cancer screening in educational campaign

3 years ago

Regeneron culls two drugs from pipeline amid double-digit revenue drop after Covid mAb cocktail pull

3 years ago

With drug price negotiations in the books, Dems turn to launch prices as the next challenge

3 years ago

AstraZeneca pulls patient data exposed on code sharing site GitHub

3 years ago

Biopharma companies to FDA: Internationally harmonize plans to standardize safety data and analysis

3 years ago

FDA still not ready to go back to actual in-person meetings with biopharma sponsors

3 years ago

Moderna's stock plunges in premarket trading as Bancel promises company is in 'much better place' for FY23 deliveries

3 years ago

Texas CDMO is cutting 60% of staff as focus shifts to drug discovery, in-house candidates

3 years ago

Manufacturing roundup: Terumo Pharmaceutical Solutions expanding CDMO reach outside Japan; EUROAPI boosting ...

3 years ago

Updated: Citing efficacy, GSK halts UTI antibiotic trial early, plans to file for FDA approval next year

3 years ago

Small startup touts a PhIII success in rare 'butterfly skin' disease after an FDA hold routed shares

3 years ago

Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager

3 years ago

After pulling IPO plans, Artiva partners with Affimed to speed up NK cell therapy combo

3 years ago

'Do the right thing': Billionaire pushes struggling biotech to return cash to investors

3 years ago

Exscientia wants to bring its AI/ML approach into the world of biologics. It's starting with antibodies

3 years ago

Compass' single-dose psilocybin shows strong efficacy in PhII treatment-resistant depression trial

3 years ago

A Chicago biotech skips the IPO in favor of late-stage Series D for a PhIII Tourette drug

3 years ago

First page Previous page 428 429 430431432 433 434 Next page Last page